M. Stuschke

发表

The value of subcutaneous xenografts for individualised radiotherapy in HNSCC: robust gene signature correlates with radiotherapy outcome in patients and xenografts.

I. Tinhofer, S. Pigorsch, F. Lohaus, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy

M. Wiesweg, N. Guberina, M. Guberina, 2024, Scientific reports.

Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment—Comparison with Stage III Disease

T. Gauler, M. Wiesweg, N. Guberina, 2024, Cancers.